On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Exelixis

FunderResearch funding and supported work

Exelixis is a funder indexed in ScholarIQ from OpenAlex.

What is known about Exelixis?

ScholarIQrecord summary

American biotechnology company

How many works does Exelixis have?

ScholarIQindexed works

Exelixis has 2,402 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Exelixis?

ScholarIQopenalex

The OpenAlex for Exelixis is on the source record.

What is the ROR of Exelixis?

ScholarIQror

The ROR for Exelixis is on the source record.

What are the most-cited papers on Exelixis?

ScholarIQmost cited works
<i>EGFR</i> -Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux, Scott Gettinger, Grainne M. O’Kane, Kathryn C. Arbour, Joel W. Neal, Hatim Husain, Tracey L. Evans, Julie R. Brahmer, Alona Muzikansky, Philip Bonomi, Salvatore Del Prete, Anna Wurtz, Anna F. Farago, Dora Dias‐Santagata, Mari Mino–Kenudson, Karen L. Reckamp, Helena A. Yu, Heather A. Wakelee, Frances A. Shepherd, Zofia Piotrowska, Lecia V. Sequist
Journal of Clinical Oncology. 2018485 Citations
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
Anish Thomas, Rasa Vilimas, Christopher Trindade, Rebecca Erwin-Cohen, Nitin Roper, Liqiang Xi, Venkatesh Krishnasamy, Elliot Levy, Andy Mammen, Samantha Nichols, Yuanbin Chen, Vamsidhar Velcheti, Fang Yin, Éva Szabó, Yves Pommier, Seth M. Steinberg, Jane B. Trepel, Mark Raffeld, Howard A. Young, Javed Khan, Stephen M. Hewitt, Jung-Min Lee
Journal of Thoracic Oncology. 2019183 CitationsOPEN ACCESS
470M+ articles · 14-day free trial